日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Metformin-Enhanced Digital Therapeutics for the Affordable Primary Prevention of Diabetes and Cardiovascular Diseases: Advancing Low-Cost Solutions for Lifestyle-Related Chronic Disorders

二甲双胍增强型数字疗法在糖尿病和心血管疾病一级预防中的经济效益:推进与生活方式相关的慢性疾病的低成本解决方案

Farley, Brian; Radetich, Emi; DAlessandro, Joseph; Bulaj, Grzegorz

Population pharmacokinetics and target attainment analysis of vancomycin after intermittent dosing in adults with cystic fibrosis

囊性纤维化成人患者间歇给药后万古霉素的群体药代动力学和目标达成情况分析

Yellepeddi, Venkata K; Lindley, Bryn; Radetich, Emi; Kumar, Shaun; Bhakta, Zubin; Leclair, Laurie; Parrot, Madison; Young, David C

Scholarly Activity of Tenure-Track Faculty in US Departments of Pharmacy Practice

美国药学系终身教职教师的学术活动

Urry, Ross C; Radetich, Emi; Tak, Casey; Munger, Mark A

Identification of broad-spectrum antiviral compounds and assessment of the druggability of their target for efficacy against respiratory syncytial virus (RSV)

鉴定广谱抗病毒化合物并评估其靶点对呼吸道合胞病毒(RSV)的成药性

Bonavia, Aurelio; Franti, Michael; Pusateri Keaney, Erin; Kuhen, Kelli; Seepersaud, Mohindra; Radetich, Branko; Shao, Jian; Honda, Ayako; Dewhurst, Janetta; Balabanis, Kara; Monroe, James; Wolff, Karen; Osborne, Colin; Lanieri, Leanne; Hoffmaster, Keith; Amin, Jakal; Markovits, Judit; Broome, Michelle; Skuba, Elizabeth; Cornella-Taracido, Ivan; Joberty, Gerard; Bouwmeester, Tewis; Hamann, Lawrence; Tallarico, John A; Tommasi, Ruben; Compton, Teresa; Bushell, Simon M

Relieving autophagy and 4EBP1 from rapamycin resistance

缓解自噬和 4EBP1 的雷帕霉素耐药性

Beat Nyfeler, Philip Bergman, Ellen Triantafellow, Christopher J Wilson, Yanyi Zhu, Branko Radetich, Peter M Finan, Daniel J Klionsky, Leon O Murphy